Log In
Print
BCIQ
Print
Print this Print this
 

Simponi, golimumab

Also known as: CNTO 148

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionHuman mAb against tumor necrosis factor (TNF) alpha
Molecular Target Tumor necrosis factor (TNF) alpha
Mechanism of ActionAntibody
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today